75 related articles for article (PubMed ID: 1774503)
1. [Mechanisms of organ failure following cardiopulmonary bypass--preventive effects of ulinastatin].
Hashimoto K; Horikoshi S; Miyamoto H; Okuyama H; Suzuki K; Matsui M; Arai T; Kurosawa H
Nihon Kyobu Geka Gakkai Zasshi; 1991 Dec; 39(12):2163-71. PubMed ID: 1774503
[TBL] [Abstract][Full Text] [Related]
2. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators.
Hashimoto K; Miyamoto H; Suzuki K; Horikoshi S; Matsui M; Arai T; Kurosawa H
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):666-73. PubMed ID: 1355150
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of organ failure following cardiopulmonary bypass--preventive effects of Ca2+ blocker (nicardipine)].
Hashimoto K; Nomura K; Suzuki K; Okuyama H; Kurosawa H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Feb; 41(2):181-6. PubMed ID: 8473780
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological intervention for renal protection during cardiopulmonary bypass.
Hashimoto K; Nomura K; Nakano M; Sasaki T; Kurosawa H
Heart Vessels; 1993; 8(4):203-10. PubMed ID: 8307900
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass].
Mishima A; Takeuti Y; Usami S; Kotani H; Suzuki Y; Yura J
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):607-12. PubMed ID: 2373894
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ulinastatin on granulocyte elastase and fibronectin in patients undergoing cardiopulmonary bypass].
Enzan K; Mitsuhata H; Masaki Y; Matsumoto J; Shigeomi S; Komatsu H; Suzuki M
Masui; 1991 Nov; 40(11):1625-31. PubMed ID: 1766113
[TBL] [Abstract][Full Text] [Related]
7. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass.
Sugita T; Watarida S; Katsuyama K; Nakajima Y; Yamamoto R; Mori A
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):437-40. PubMed ID: 12124548
[TBL] [Abstract][Full Text] [Related]
8. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
9. [Protective effects of ulinastatin on the lung injury during cardiopulmonary bypass].
Wang DJ; Liu JX; Yin BL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):670-2. PubMed ID: 16708806
[TBL] [Abstract][Full Text] [Related]
10. [Effect of TXA2 on renal lysosomal membrane].
Arima T; Matsumoto I; Hori T
Masui; 1989 Dec; 38(12):1567-73. PubMed ID: 2614884
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass].
Ueki M; Yokono S; Nogaya J; Taie S; Komatsu H; Nakano M; Ogli K
Masui; 1995 May; 44(5):691-7. PubMed ID: 7609298
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of ulinastatin as a radical scavenger for protection of reperfusion injury after myocardial ischemia in open heart surgery].
Kawai T; Wada Y; Nishiyama K; Kanki Y; Ohga K; Oka T; Yasuda M; Yoshikawa T
Nihon Kyobu Geka Gakkai Zasshi; 1991 Dec; 39(12):2157-62. PubMed ID: 1774502
[TBL] [Abstract][Full Text] [Related]
13. [Effect of tetramethylpyrazine on endothelin, von Willebrand factor and thromboxane A2 during cardiopulmonary bypass in patients of congenital heart disease with pulmonary hypertension].
Huang RJ; Liao CX; Chen DZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):268-71. PubMed ID: 12764908
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Salvia miltiorrhiza compound injection on serum endothelin, prostaglandin I2/thromboxane A2 ratio alteration following myocardial ischemia-reperfusion in patients undergoing intracardiac surgery].
Shi X; Xia Z; Fang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Dec; 20(12):896-8. PubMed ID: 11938858
[TBL] [Abstract][Full Text] [Related]
15. Changes in urinary thromboxane level in man during cardiopulmonary bypass: effect of thromboxane on renal tubules.
Arima T; Shiramatsu T; Matsuura M; Nakamura S; Matsumoto I; Hori T
Prostaglandins; 1990 Mar; 39(3):319-38. PubMed ID: 2339202
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
[TBL] [Abstract][Full Text] [Related]
17. Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery.
Nagaoka H; Innami R; Murayama F; Funakoshi N; Hirooka K; Watanabe M; Satoh M
J Cardiovasc Surg (Torino); 1991; 32(1):31-7. PubMed ID: 1707053
[TBL] [Abstract][Full Text] [Related]
18. [Arachidonic acid metabolism and effectiveness of aprotinin treatment during cardiopulmonary bypass].
Nagaoka H; Innami R; Funakoshi N; Fujiwara A; Itoh J
Nihon Kyobu Geka Gakkai Zasshi; 1991 Sep; 39(9):1723-30. PubMed ID: 1720445
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease.
Xia Z; Gu J; Ansley DM; Xia F; Yu J
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1404-10. PubMed ID: 14666012
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
